• KOLs
  • Small Lymphocytic Lymphoma

Location & Type arrow_drop_up Concepts arrow_drop_down Orgs arrow_drop_down
Filter by Concept
#1
Loxo Oncology, Inc.
Loxo Oncology, Inc.
Known for star star star star star
Solid Tumors | Lymphocytic Lymphoma | Btk Inhibitor | Medullary Thyroid
#2
SecuraBio
SecuraBio
Known for star star star star star
Follicular Lymphoma | Chronic Lymphocytic | Phase Duvelisib | Hepatic Impairment

#3
BeiGene
BeiGene
Known for star star star star star
Solid Tumors | Monoclonal Antibody | Safety Tolerability | Locally Advanced
#4
BeiGene, Ltd.
BeiGene, Ltd.
Known for star star star star star_half
Small Lymphocytic | Zanubrutinib Bgb-3111 | Tislelizumab Bgb | Treated Recurrent
#5
Jose F. Leis
Jose F. Leis
Division of Hematology/Oncology, College of Medicine, Mayo Clinic, Phoenix, Arizona, USA
Known for star star star star star_half
Lymphocytic Leukemia | Cancer Cells | Everolimus Alemtuzumab | Lenalidomide Therapy
#6
Clive S. Zent
Clive S. Zent
Known for star star star star star_half
Chronic Lymphocytic | Alemtuzumab Rituximab | Cancer Cells | Antibody Therapy
#7
Alexey Danilov, MD
Alexey Danilov, MD
Known for star star star star star_half
Lymphocytic Lymphoma | Refractory Chronic | Entospletinib Obinutuzumab | Leukemia Small
#8
Tait Shanafelt
Tait Shanafelt
Known for star star star star star_half
Lymphocytic Leukemia | Immune Response | Refractory Chronic | Pentostatin Cyclophosphamide
#9
Kai Hu
Kai Hu
Civil Engineering Department, Tongji University, 200092, Shanghai, China
Known for star star star star star_half
Refractory Diffuse | Relapsed Cd7 | Lymphocytic Lymphoma | T2c Car
#10
Telios Pharma, Inc.
Telios Pharma, Inc.
Known for star star star star star_half
Kinase Inhibitor | Refractory Myelofibrosis | Myeloid Leukemia | Lymphocytic Lymphoma
#11
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC
Known for star star star star star_half
Breast Cancer | Radiation Therapy | Solid Tumors | Phase Trial
#12
Loxo Oncology Inc
Loxo Oncology Inc
Known for star star star star star_half
Chronic Lymphocytic | Pirtobrutinib Loxo-305 | Lymphoma Bruin | Leukemia Small
#13
Januario Castro
Januario Castro
Known for star star star star star_half
Repeat Intranodal | Chronic Lymphocytic | Isf35 Phase | Rituximab Cycle
#14
Memgen, LLC
Memgen, LLC
Known for star star star star star_half
Repeat Intranodal | Autologous Cll | Cells Transduced | Isf35 Phase
#15
Safi Shahda
Safi Shahda
Known for star star star star star_half
Lymphocytic Leukemia | Btk Inhibitor | Solid Tumors | Loxo-305 Arm
#16
Neil E Kay
Neil E Kay
Known for star star star star star_half
Motexafin Gadolinium | Chronic Lymphocytic | Leukemia Small | Response Rate
#17
Tait D. Shanafelt
Tait D. Shanafelt
Known for star star star star star_half
Lymphocytic Leukemia | Pentostatin Cyclophosphamide | Cancer Cells | Tea Extract

 

Recently Asked Questions

View all FAQs

Bifid Uvula The bifid uvula is a small, triangular piece of tissue that hangs down from the center of the back of the palate (roof of the mouth). It is located just...

 

Pelvic Congestion Pelvic congestion is a condition that affects women and is characterized by the enlargement of veins in the pelvis. These veins can become twisted and...

 

Schizophreniform Disorder Schizophreniform disorder is a mental illness that is characterized by the presence of symptoms similar to those seen in schizophrenia, but which last for a...

 

Elbow Dislocation Elbow dislocation occurs when the bones that make up the elbow joint are forced out of alignment. This can happen as a result of a fall, direct blow, or...

 

Metastatic Lung Cancer Metastatic lung cancer, also known as stage IV lung cancer, is a type of cancer that has spread from the lungs to other parts of the body. While lung cancer...

 

An Open-Label, Phase 1/2 Study Of Jcar017 In Subjects With Relapsed Or Refractory...

[ CLINICAL_TRIAL ] This is a Phase 1/2, open-label, multicenter study to determine the efficacy and safety of JCAR017 in adult subjects with relapsed or refractory CLL or SLL. The study will include a Phase 1 part ...
Known for star star star star star
Lymphocytic Leukemia | Phase Jcar017 | Refractory Chronic | Cll Sll

Randomized, Phase Iii Study Of Early Intervention With Venetoclax And...

[ CLINICAL_TRIAL ] ... or small lymphocytic lymphoma. Venetoclax may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...
Known for star star star star star
Venetoclax Obinutuzumab | Leukemia Cll | Arms Secondary | Chronic Lymphocytic

National Prospective And Retrospective Follow-Up Of Patients With Covid-19...

[ CLINICAL_TRIAL ] ... / lymphocytic lymphoma or Waldenstrom Disease (WD)
Known for star star star star star
Lymphocytic Lymphoma | Covid-19 Infected | Epidemic Coronavirus | Linked Sars

A Single-Arm, Open-Label, Multi-Center Phase Ib/ii Study Of Tq-B3525 In Subjects...

[ CLINICAL_TRIAL ] ... leukemia/small lymphocytic lymphoma.. This is a study to evaluate the efficacy and safety of TQ-B3525 in subjects with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Known for star star star star star_half
Lymphocytic Leukemia | Refractory Chronic | Center Phase | B3525 Relapsed

A Phase 2 Study Of Oral Loxo-305 In Patients With Previously Treated Chronic...

[ CLINICAL_TRIAL ] ... with lymphoma or chronic leukemia who have already had standard of care treatment. Participation could last up to four years.. A study of the safety, side effects, and effectiveness of ...
Known for star star star star star_half
Chronic Lymphocytic | Oral Loxo-305 | Hodgkin Lymphoma | Chinese Adults

A Randomized, Controlled, Open, Multicenter Phase 3 Study To Evaluate Icp-022...

[ CLINICAL_TRIAL ] ... Chronic Lymphocytic Leukemia.. This is a randomized, multicenter, open-label, Phase 3 study to evaluate the efficacy and safety of ICP-022 versus Chlorambucil plus Rituximab in subjects ...
Known for star star star star star_half
Chronic Lymphocytic | Evaluate Icp-022 | Multicenter Phase | Chlorambucil Combined

Randomized Phase 2 Study Comparing Acalabrutinib To Acalabrutinib And...

[ CLINICAL_TRIAL ] ... or small lymphocytic lymphoma. Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...
Known for star star star star star_half
Stage Chronic | Lymphocytic Lymphoma | Acalabrutinib Obinutuzumab | Cycles Arm

A Phase I/ii Study Of Syk Inhibitor Entospletinib (Gs-9973) In Combination With...

[ CLINICAL_TRIAL ] ... leukemia, small lymphocytic lymphoma, or non-Hodgkin lymphoma that has come back. Entospletinib may stop the growth of cancer cells by blocking some of the enzymes need for cell growth. ...
Known for star star star star star_border
Lymphocytic Lymphoma | Refractory Chronic | Entospletinib Obinutuzumab | Response Phase

Phase Ii Trial Of Pentostatin, Cyclophosphamide, And Rituximab Followed By...

[ CLINICAL_TRIAL ] RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill ...
Known for star star star star star_border
Lymphocytic Lymphoma | Lenalidomide Therapy | Cancer Cells | Rituximab Consolidation

A Phase 1, Multicenter, Dose Escalation Study Of Cat-8015 In Patients With...

[ CLINICAL_TRIAL ] ... or small lymphocytic lymphoma (SLL that has not responded to chemotherapy, surgery or radiation therapy.PURPOSE: Phase I dose escalation study to determine the maximum tolerated dose of ...
Known for star star star star star_border
Lymphocytic Leukemia | Cat-8015 Immunotoxin | Refractory Chronic | Cll Pll